Innovative drugs and devices are being made more accessible in general across the region, while public healthcare coverage differs substantially from country to country, giving rise to a range of hybrid, multi-payment systems and different types of public-private partnerships.
- All
- AI and Emerging Technology Integration
- Aviation
- Capital Markets
- Company News
- Consumer Brands
- Content Strategy
- Corporate Communications
- Crisis and Issues Communications Management
- Digital Communications
- Education
- Energy and Environment
- Financial
- Government and Public affairs
- Health
- International media
- Media Relations
- Multimedia Design and Production
- Primary Industries
- Professional Services
- Property and Infrastructure
- Public Relations
- Research
- Strategy
- Technology
- Travel and Hospitality
Respiratory illnesses continue to surge globally following the COVID-19 pandemic, posing a growing challenge to the healthcare systems, especially in the Asia-Pacific region.
An exclusive preview of Sandpiper Health's upcoming patient advocacy group survey report that unlocks insights of patient needs.
According to the UN Economic and Social Commission for Asia and the Pacific’s (ESCAP) 2024 SDG Progress Report, the Asia-Pacific region is lagging 32 years behind reaching SDGs by 2030. So what are the underdeveloped areas? And how can we tackle them?
The recent promising clinical trial results of Wegovey, an obesity drug, has sent its manufacturer's share soaring, indicating the business potential in obesity treatment and prevention.
2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.
- All
- AI and Emerging Technology Integration
- Aviation
- Capital Markets
- Company News
- Consumer Brands
- Content Strategy
- Corporate Communications
- Crisis and Issues Communications Management
- Digital Communications
- Education
- Energy and Environment
- Environmental, Social and Governance (ESG)
- Financial
- Government and Public affairs
- Health
- International media
- Media Relations
- Multimedia Design and Production
- Primary Industries
- Professional Services
- Property and Infrastructure
- Public Relations
- Research
- Strategy
- Technology
- Travel and Hospitality
Innovative drugs and devices are being made more accessible in general across the region, while public healthcare coverage differs substantially from country to country, giving rise to a range of hybrid, multi-payment systems and different types of public-private partnerships.
Respiratory illnesses continue to surge globally following the COVID-19 pandemic, posing a growing challenge to the healthcare systems, especially in the Asia-Pacific region.
An exclusive preview of Sandpiper Health's upcoming patient advocacy group survey report that unlocks insights of patient needs.
According to the UN Economic and Social Commission for Asia and the Pacific’s (ESCAP) 2024 SDG Progress Report, the Asia-Pacific region is lagging 32 years behind reaching SDGs by 2030. So what are the underdeveloped areas? And how can we tackle them?
The recent promising clinical trial results of Wegovey, an obesity drug, has sent its manufacturer's share soaring, indicating the business potential in obesity treatment and prevention.
2024 is bringing a new set of changes, challenges, and opportunities to Asia Pacific’s healthcare sector. Shifting demographics, social changes, and new technologies such as cell and gene therapies, bio-inductive implants, and AI-assisted discovery are expected to reshape the industry.